By: Maribel Yoo On: March 17, 2017 In: Seed Senior Advisory Board Comments: 0
Eugene de Juan, Jr. – Website Full

Eugene de Juan, Jr.

Nexus Venture Partner

Distinguished Professor of Ophthalmology, University of California, San Francisco
Managing Partner, ForSight Labs

Ophthalmology, Drug Delivery, Early Stage Company Development

EDUCATION
BS – Emory University
MS – University of Alabama in Birmingham
MD – University of South Alabama

AWARDS AND ACCOLADES
Lifetime Achievement Award: American Academy of Ophthalmology
Industry Innovator of the Year Award (OIS)
Catalyst Award: Glaucoma Research Foundation
Heed-Gutman Award: The Society of Heed Fellows

COMPANIES AND BOARDS
Co-Founder – Azura, Second Sight (NASDAQ:EYES), InnoRx (acquired by Surmodics), NeoVista (acquired by Orya), Retina Lab (acquired by Iridex), Transcend Medical (acquired by Novartis); ForSight VISION 1- 6; [ForSight VISION 2 (acquired by QLT), ForSight VISION 4 acquired by Genentech/Roche), ForSight VISION5 (acquired by Allergan)]

Board of Directors – Sprial Therapuetics, ForSight Vision 6, Presby, Voyant, Nexis Vision, Inc. (formerly ForSight VISION3)